Published in Clin Exp Immunol on September 01, 1985
CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. Autoimmune Dis (2012) 1.20
Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy. Clin Transl Immunology (2014) 0.92
Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes. BMC Neurol (2011) 0.91
Circulating T-cell populations during mercuric chloride-induced nephritis in the Brown Norway rat. Immunology (1987) 0.86
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis. Mult Scler (2014) 0.81
Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients. Clin Exp Immunol (1987) 0.80
Peripheral blood lymphocyte phenotype and function in multiple sclerosis. J Neurol Neurosurg Psychiatry (1988) 0.77
Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis. Clin Transl Immunology (2017) 0.75
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl (1968) 60.35
Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol (1971) 20.35
Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol (1966) 18.33
Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer (1973) 14.90
A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Methods (1981) 10.77
Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer (1978) 2.81
Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med (1980) 2.21
Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro. J Gen Virol (1972) 2.18
Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus. J Exp Med (1973) 2.11
T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. Cell Immunol (1984) 2.01
Deficit of suppressor T cells in active multiple sclerosis. Lancet (1980) 1.83
Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol (1984) 1.81
Analysis of T cell subsets in the peripheral blood and synovial fluid of patients with rheumatoid arthritis by means of monoclonal antibodies. Ann Rheum Dis (1983) 1.64
Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest (1981) 1.63
Neuroimmunology I: Immunoregulation in neurological disease. Ann Neurol (1982) 1.48
Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor. Clin Exp Immunol (1980) 1.47
Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis. Proc Natl Acad Sci U S A (1979) 1.47
Disease activity markers in multiple sclerosis. Another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5, and OKT8. J Neuroimmunol (1984) 1.18
Characterization of blood mononuclear cells of rheumatoid arthritis patients. I. Depressed lymphocyte proliferation and enhanced prostanoid release from monocytes. Clin Immunol Immunopathol (1982) 1.18
Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol (1979) 1.17
Lymphocyte subpopulations in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry (1983) 1.16
Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis. Clin Exp Immunol (1982) 1.14
Peripheral blood lymphocyte sub-populations and multiple sclerosis. J Neuroimmunol (1984) 1.13
Significance of virus antibodies in multiple sclerosis. Br Med Bull (1977) 1.06
Suppressor T-lymphocytes in multiple sclerosis: analysis of patients with acute relapsing and chronic progressive disease. Ann Neurol (1983) 1.06
Analysis of suppressor T cell function in patients with rheumatoid arthritis: defects in production of and responsiveness to concanavalin A-induced suppressor T cells. J Immunol (1982) 1.05
Immunoregulatory T-cells and lymphocytotoxic antibodies in active multiple sclerosis: weekly analysis over a six-month period. Ann Neurol (1983) 1.04
Interferon responses of leukocytes in multiple sclerosis. Neurology (1981) 1.04
Altered regulation of mitogen responsiveness by suppressor cells in multiple sclerosis. Clin Exp Immunol (1979) 1.01
Epstein-Barr virus-specific cytotoxic T cell responses in rheumatoid arthritis patients. Rheumatol Int (1982) 0.99
Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patients. J Neurol Sci (1983) 0.99
Altered blood T-cell subsets in patients with multiple sclerosis. J Neuroimmunol (1984) 0.97
Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis. J Immunol (1984) 0.96
Decreased NK killing in patients with multiple sclerosis: an analysis on the level of the single effector cell in peripheral blood and cerebrospinal fluid in relation to the activity in the disease. Clin Exp Immunol (1982) 0.94
Lymphocyte populations in the cerebrospinal fluid and peripheral blood of patients with multiple sclerosis and optic neuritis. Scand J Immunol (1983) 0.91
Defective production of interferon-alpha associated with HLA-DW2 antigen in stable multiple sclerosis. J Neurol Sci (1982) 0.90
Natural killer cell activity in multiple sclerosis. J Immunol (1981) 0.90
T-cell subsets in multiple sclerosis: a comparative study between cell surface antigens and function. Clin Immunol Immunopathol (1984) 0.89
The significance of abnormal immune responses in patients with multiple sclerosis. J Neuroimmunol (1981) 0.89
T-cell subpopulations in blood and cerebrospinal fluid of multiple sclerosis patients: effect of cyclophosphamide. Clin Immunol Immunopathol (1983) 0.87
Measles virus-specific antibodies and immunoglobulin M antiglobulin in sera from multiple sclerosis and rheumatoid arthritis patients. Infect Immun (1979) 0.87
Defective immunoregulation in multiple sclerosis. Ann Neurol (1980) 0.86
Cellular interaction between subsets of T8 population for maximal suppression of antigen-specific antibody response. Cell Immunol (1984) 0.82
Lack of correlation between impaired interferon production and natural killer activity of lymphocytes in multiple sclerosis. Arch Virol (1982) 0.80
Abnormalities of immunocyte function in multiple sclerosis. Acta Neuropathol Suppl (1983) 0.78
T-cell control of herpesvirus infections: lessons from the Epstein-Barr virus. Prog Brain Res (1983) 0.76
Rational design of peptide-based HIV proteinase inhibitors. Science (1990) 4.57
Immunoglobulin responses in rubella and its complications. Br Med J (1970) 4.01
Consultations in general practice. Analysis of individual frequencies. Br J Prev Soc Med (1969) 3.72
Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev (2008) 3.46
The neurological practice of a district general hospital. J Neurol Neurosurg Psychiatry (1987) 3.15
Symptoms at one year following concussion from minor head injuries. Injury (1979) 2.64
The injuries of terrorist bombing: a study of 1532 consecutive patients. Br J Surg (1978) 2.63
Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959. Virology (1995) 2.29
Short compared with standard duration of antibiotic treatment for urinary tract infection: a systematic review of randomised controlled trials. Arch Dis Child (2002) 2.28
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev (2006) 2.13
Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec (1998) 2.05
Immunoglobulin M specific for measles and mumps in multiple sclerosis. Br Med J (1971) 2.04
Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled trials. Arch Dis Child (2003) 1.99
Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect (2007) 1.84
Rapid diagnosis of rubella by demonstrating rubella-specific IgM antibodies in ther serum by indirect immunofluorescence. J Med Microbiol (1972) 1.82
Comparison of the handling of neurological outpatient referrals by general physicians and a neurologist. J Neurol Neurosurg Psychiatry (1993) 1.78
Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation. Mol Cell Biol (2000) 1.78
Further studies with quadruple vaccine. J Hyg (Lond) (1966) 1.77
An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology (1998) 1.72
Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children. Cochrane Database Syst Rev (2003) 1.72
Structural features of the colony-stimulating factor 1 receptor that affect its association with phosphatidylinositol 3-kinase. EMBO J (1990) 1.72
New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet (1997) 1.70
The effect of dicynene on blood loss during and after transurethral resection of the prostate. Br J Urol (1975) 1.67
Oral inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE). 1. Onset and distribution of disease-specific PrP accumulation in brain and viscera. J Comp Pathol (2001) 1.60
Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev (2005) 1.60
Daytime urinary incontinence in primary school children: a population-based survey. J Pediatr (2000) 1.58
Measles and other virus-specific immunoglobulins in multiple sclerosis. Br Med J (1973) 1.57
A survey of dust concentrations in flax mills in Northern Ireland. Br J Ind Med (1965) 1.54
The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. Kidney Int (2007) 1.53
Renal impairment and anaemia in a population-based study of older people. Intern Med J (2004) 1.51
Measles immunoglobulins in subacute sclerosing panencephalitis. Br Med J (1971) 1.50
Growth hormone treatment in children with chronic renal failure: a meta-analysis of randomized controlled trials. J Pediatr (2001) 1.48
Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database Syst Rev (2008) 1.48
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev (2008) 1.47
Virus-specific immunoglobulins in multiple sclerosis. Clin Exp Immunol (1973) 1.45
Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course. Mult Scler (2004) 1.45
Texture perception through direct and indirect touch: an analysis of perceptual space for tactile textures in two modes of exploration. Somatosens Mot Res (2007) 1.43
Sexually transmitted diseases, T cell subsets, and sexual practices in homosexual men attending an STD clinic. Genitourin Med (1985) 1.40
Prevalence of byssinosis and dust levels in flax preparers in Northern Ireland. Br J Ind Med (1966) 1.40
An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis. J Neurol Sci (2000) 1.40
The Royal Group of Hospitals Arts and Environment Project. Ulster Med J (1993) 1.39
New weakness in a critically ill patient. Postgrad Med J (1999) 1.39
Stereochemistry of 1-(4'-hydroxyphenyl)ethanol produced by hydroxylation of 4-ethylphenol by p-cresol methylhydroxylase. Biochem J (1984) 1.38
Superficial siderosis of the central nervous system many years after neurosurgical procedures. J Neurol Neurosurg Psychiatry (2003) 1.37
Evaluation of the immunological specificity of fluorescein-labelled anti-human IgM conjugates. Immunology (1972) 1.37
Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients. Am J Transplant (2007) 1.37
Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev (2007) 1.34
Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst Rev (2008) 1.32
Metabolic fate of extracted glucose in normal human myocardium. J Clin Invest (1985) 1.26
Further studies with a diphtheria-tetanus-poliomyelitis vaccine. J Hyg (Lond) (1966) 1.23
Carotid artery thrombosis, encephalitis, myelitis and optic neuritis associated with rubella virus infections. Brain (1975) 1.23
Antibiotics in surgical treatment of septic lesions. Lancet (1970) 1.21
Smooth muscle actin expression during P19 embryonal carcinoma differentiation in cell culture. J Cell Physiol (1990) 1.20
Intersphincteric excision of the rectum. Br J Surg (1977) 1.19
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev (2006) 1.19
Neurological examination is possible using telemedicine. J Telemed Telecare (1999) 1.18
Platelet stickiness in multiple sclerosis. J Neurol Neurosurg Psychiatry (1966) 1.18
Infectivity in the ileum of cattle challenged orally with bovine spongiform encephalopathy. Vet Rec (1994) 1.18
Fibrillar anti-cellular antibody associated with mumps and measles infection. Clin Exp Immunol (1972) 1.17
Corticosteroid therapy in nephrotic syndrome: a meta-analysis of randomised controlled trials. Arch Dis Child (2000) 1.17
Smooth muscle antibody in patients with warts. Clin Exp Immunol (1975) 1.14
Mycoplasmas in cell cultures from rheumatoid synovial membranes. J Hyg (Lond) (1971) 1.14
Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev (2005) 1.14
Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev (2006) 1.12
A controlled trial of immediate and delayed closure of myelomeningocele. J Bone Joint Surg Br (1974) 1.11
Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev (2007) 1.08
Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment. Diabet Med (1988) 1.08
Influence of visual motion on tactile motion perception. J Neurophysiol (2006) 1.07
Nicotine in breast fluid of nonlactating women. Science (1978) 1.07
Significance of virus antibodies in multiple sclerosis. Br Med Bull (1977) 1.06
A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry (1989) 1.06
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients. Cochrane Database Syst Rev (2006) 1.05
Traumatic Brown-Séquard-plus syndrome. Arch Neurol (2001) 1.05
Smoking in pregnancy--a health education problem. J R Coll Gen Pract (1986) 1.05
Visual field abnormalities in multiple sclerosis. J Neurol Neurosurg Psychiatry (1980) 1.04
Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev (2007) 1.04
Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease. Cochrane Database Syst Rev (2006) 1.03
Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database Syst Rev (2005) 1.03
Distribution of measles antigen and immunoglobulin-containing cells in the CNS in subacute sclerosing panencephalitis (SSPE) and atypical measles encephalitis. J Neurol Sci (1982) 1.01
Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function. Cochrane Database Syst Rev (2007) 1.00
Relation of alpha-1-antitrypsin phenotype to the performance of pulmonary function tests and to the prevalence of respiratory illness in a working population. Thorax (1976) 1.00
Relationship between physiological loss, performance decrement, and age in master athletes. J Gerontol A Biol Sci Med Sci (2001) 1.00
Serum neurone-specific enolase as an indicator of stroke volume. Eur J Clin Invest (1996) 0.99
A prospective study of liver enzyme and other changes following repeat administration of halothane and enflurane. Br J Anaesth (1979) 0.99
Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch Neurol (1987) 0.98
Diagnosis and results of surgery in renovascular hypertension. Lancet (1966) 0.98
SA1 and RA afferent responses to static and vibrating gratings. J Neurophysiol (2005) 0.98
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev (2005) 0.98
Primary squamous carcinoma of the proximal large bowel. Report of a case and review of the literature. Dis Colon Rectum (1983) 0.98
Resistance and cross-resistance with saquinavir and other HIV protease inhibitors: theory and practice. AIDS (1998) 0.97
Parental perspectives on caring for a child with chronic kidney disease: an in-depth interview study. Child Care Health Dev (2010) 0.97
Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK. J Neurol Neurosurg Psychiatry (1998) 0.96
Rapid test for the preclinical postmortem diagnosis of BSE in central nervous system tissue. Vet Rec (2001) 0.96
Influence of social class on the risk of recurrence of anencephalus and spina bifida. Dev Med Child Neurol (1981) 0.96
A controlled trial of imipramine ('Tofranil') and nortriptyline ('Allegron') in the treatment of enuresis. Br J Clin Pract (1969) 0.96
Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96